Comparative Study of the efficacy of tramadol and fentanyl as adjuvant to bupivacaine on brachial plexus block: A Double blind, Prospective, Randomized Study

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR202001635673534

Enrollment

Registered

2020-01-31

Start date

2018-10-01

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

bupivacaine alone

bupivacaine with tramadol

experment group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All ASA I and II Age between 18-60 Elective upper limb orthopedic surgeries under axillary block

Exclusion criteria

Exclusion criteria: Uncooperative to perform the block (psychiatric disorder) Known allergy (for bupivacaine, tramadol or fentanyl) Infection on the site of injection /around the axilla Patient refusal Contraindication for axillary block

Design outcomes

Primary

Measure	Time frame
Comparison of time to onset of compete sensory and motor block, Comparison of duration for sensory and motor block, time to first analgesic request, Comparison of Postoperative Numeric Pain Rating scale and Comparison of total analgesic consumption within 24 hours after incision,	—

Secondary

Measure	Time frame
Comparison of adverse effects (nausea/vomiting)	—

Countries

Ethiopia

Contacts

Public ContactEfrem Fenta

Lecturer

ephfen2007@gmail.com+251966261787

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 19, 2026